Proactive Wealth Strategies
GSK icon

Proactive Wealth Strategies’s GSK GSK Stock Holding History

Proactive Wealth Strategies’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$328K Buy
6,800
+58
+0.9% +$2.96K 0.05% 179
2026
Q2 		$353K Buy
6,742
+54
+0.8% +$2.86K 0.06% 173
2026
Q1 		$369K Buy
+6,688
New +$362K 0.07% 165

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $187B AUM 13.73% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return
JTC Employer Solutions Trustee
JTC Employer Solutions Trustee St Helier, Jersey $1.16B AUM 24.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Mondrian Investment Partners
Mondrian Investment Partners London, United Kingdom $5.39B AUM 14.53% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $46.6B AUM 32.12% 1-Year Est. Return

Proactive Wealth Strategies's GSK Position: Q3 2026 in Review

Proactive Wealth Strategies increased its GSK (GSK) stake by 0.86% in Q3 2026, buying an estimated $2.96K and bringing the position to 6,800 shares worth $328K. The position accounts for 0.05% of the portfolio, ranked #179.

Proactive Wealth Strategies first reported a position in GSK in Q1 2026 and has held it in 3 quarters since. The position peaked at $369K in Q1 2026. 854 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • Proactive Wealth Strategies held 6,800 shares of GSK worth $328K as of Q3 2026.
  • Proactive Wealth Strategies bought 58 GSK shares in Q3 2026, an estimated $2.96K.
  • GSK made up 0.05% of Proactive Wealth Strategies's portfolio in Q3 2026, its #179 holding.
  • Proactive Wealth Strategies first reported a position in GSK in Q1 2026 and has held it in 3 quarters since.
  • Proactive Wealth Strategies's GSK position peaked at $369K in Q1 2026.
  • 854 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Proactive Wealth Strategies's 13F filing for Q3 2026, filed 9 Nov 2026.